These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuropharmacology of cognition and memory: a unifying theory of neuromodulator imbalance in psychiatry and amnesia. Vakalopoulos C Med Hypotheses; 2006; 66(2):394-431. PubMed ID: 16300905 [TBL] [Abstract][Full Text] [Related]
5. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models. Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439 [TBL] [Abstract][Full Text] [Related]
6. Psychopharmacological strategies in the search for cognition enhancers. Sanger DJ; Joly D Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():70-4. PubMed ID: 2186417 [TBL] [Abstract][Full Text] [Related]
7. On the trail of a cognitive enhancer for the treatment of schizophrenia. Stip E; Chouinard S; Boulay LJ Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):219-32. PubMed ID: 15694228 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology of human memory and cognition: illustrations from the effects of benzodiazepines and cholinergic drugs. Danion JM; Weingartner H; File SE; Jaffard R; Sunderland T; Tulving E; Warburton DM J Psychopharmacol; 1993 Jan; 7(4):371-7. PubMed ID: 22291001 [TBL] [Abstract][Full Text] [Related]
9. Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Sarter M; Hasselmo ME; Bruno JP; Givens B Brain Res Brain Res Rev; 2005 Feb; 48(1):98-111. PubMed ID: 15708630 [TBL] [Abstract][Full Text] [Related]
11. Attention-deficit/hyperactivity disorder: neurophysiology, information processing, arousal and drug development. Rowe DL; Hermens DF Expert Rev Neurother; 2006 Nov; 6(11):1721-34. PubMed ID: 17144785 [TBL] [Abstract][Full Text] [Related]
12. The canine model of human cognitive aging and dementia: pharmacological validity of the model for assessment of human cognitive-enhancing drugs. Studzinski CM; Araujo JA; Milgram NW Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):489-98. PubMed ID: 15795058 [TBL] [Abstract][Full Text] [Related]
13. Brain cholinergic vulnerability: relevance to behavior and disease. McKinney M; Jacksonville MC Biochem Pharmacol; 2005 Oct; 70(8):1115-24. PubMed ID: 15975560 [TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement. Brousseau G; Rourke BP; Burke B Exp Clin Psychopharmacol; 2007 Dec; 15(6):546-54. PubMed ID: 18179307 [TBL] [Abstract][Full Text] [Related]
15. Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging. Araujo JA; Studzinski CM; Milgram NW Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):411-22. PubMed ID: 15795050 [TBL] [Abstract][Full Text] [Related]
16. The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease. Wright JW; Harding JW J Renin Angiotensin Aldosterone Syst; 2008 Dec; 9(4):226-37. PubMed ID: 19126664 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in cholinergic drugs for Alzheimer's disease. Clader JW Curr Opin Drug Discov Devel; 1999 Jul; 2(4):311-20. PubMed ID: 19649959 [TBL] [Abstract][Full Text] [Related]
18. [Cognitive functions, their development and modern diagnostic methods]. Klasik A; Janas-Kozik M; Krupka-Matuszczyk I; Augustyniak E Przegl Lek; 2006; 63 Suppl 1():29-34. PubMed ID: 17471820 [TBL] [Abstract][Full Text] [Related]
19. Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat. Waters KA; Burnham KE; O'connor D; Dawson GR; Dias R J Psychopharmacol; 2005 Mar; 19(2):149-58. PubMed ID: 15728436 [TBL] [Abstract][Full Text] [Related]
20. The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents. van der Staay FJ; Rutten K; Bärfacker L; Devry J; Erb C; Heckroth H; Karthaus D; Tersteegen A; van Kampen M; Blokland A; Prickaerts J; Reymann KG; Schröder UH; Hendrix M Neuropharmacology; 2008 Oct; 55(5):908-18. PubMed ID: 18674549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]